HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$64.12
-1.07 (-1.64%)
Analyst Consensus
Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
-67.2% upside
Low Target
$15.29
Average Target
$21.02
High Target
$24.22
Current Price
$64.12
Current
$64.12
$64.12
Target
$21.02
$21.02
$15.29
$21.02 avg
$24.22
Scenario Analysis
Bear Case
$15.29
-76.2%
Low target
Base Case
$21.02
-67.2%
Avg target
Bull Case
$24.22
+-62.2%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$82.22
-22.0% from high
52-Week Low
$47.50
+35.0% from low
50-Day SMA
$71.23
-10.0% vs SMA
200-Day SMA
$65.75
-2.5% vs SMA
RSI (14)
47.6
Neutral
Target vs 52W High
$21.02
-74.4% vs high
Next Earnings Report
May 12, 2026
2d
until earnings
EPS Est: $1.56
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 72% | $257.58 | +27.8% |
| AMGN | Hold | 43 | 49% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 26 | 96% | $143.40 | +41.5% |